Bal Pharma Share Price
101.16+0.49 (+0.49%)
+19.94% past 1 Year
Corporate filings & documents
Announcements
Clarification regarding Movement in Price asper attachment
1 week agoClarification regarding Movement in Price asper attachment
1 week agoThe Exchange has sought clarification from Bal Pharma Ltd on September 10 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
1 week agoThe Exchange has sought clarification from Bal Pharma Ltd on September 10 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
1 week agoConfirming the Allotment of Convertible Warrants on Preferential basis
1 week agoConfirming the Allotment of Convertible Warrants on Preferential basis
1 week agoIn Continuation of Previous intimation hereby informing 17th September 2026 fixed as Record date for payment of final dividend and communication to shareholders regarding TDS on dividend payment
3 weeks agoIn Continuation of Previous intimation hereby informing 17th September 2026 fixed as Record date for payment of final dividend and communication to shareholders regarding TDS on dividend payment
3 weeks agoBal Pharma Limited Annual Report 2026
3 weeks agoBal Pharma Limited Annual Report 2026
3 weeks ago39th AGM of the Company Scheduled on 24th September 2026. Notice copy enclosed
3 weeks ago39th AGM of the Company Scheduled on 24th September 2026. Notice copy enclosed
3 weeks agoThis is to inform that 39th AGM of Bal Pharma Limited Scheduled to be held on Thursday 24th September 2026 at 11.00 AM through VC Mode.
3 weeks agoThis is to inform that 39th AGM of Bal Pharma Limited Scheduled to be held on Thursday 24th September 2026 at 11.00 AM through VC Mode.
3 weeks agoThis is in Continuation of Company earlier intimation made in connection with allotment of warrants hereby clarify that utilization of net proceeds or tenure of warrants is 18 month from the date of allotment subject to requisite in- principle approval of the stock exchanges.
3 weeks agoThis is in Continuation of Company earlier intimation made in connection with allotment of warrants hereby clarify that utilization of net proceeds or tenure of warrants is 18 month from the date of allotment subject to requisite in- principle approval of the stock exchanges.
3 weeks agoIn Continuation of Outcome of Board meeting dated August 12 2026 Published Unaudited Financial result for the quarter ended 30th June 2026 and IEPF Notice in Financial express and Sanjevani Newspapers on 13th August 2026
1 month agoIn Continuation of Outcome of Board meeting dated August 12 2026 Published Unaudited Financial result for the quarter ended 30th June 2026 and IEPF Notice in Financial express and Sanjevani Newspapers on 13th August 2026
1 month agoEnclosed Financial Result for the First quarter ended 30th June 2026 together with Limited Review Report as submitted by Statutory auditor
1 month agoEnclosed Financial Result for the First quarter ended 30th June 2026 together with Limited Review Report as submitted by Statutory auditor
1 month agoBoard of directors of the Company met on Wednesday August 12 2026 inter alia transacted the following business.1. Considered and approved the unaudited Financial Results (Standalone and Consolidated) of the Company quarter ended on 30th June 20262. Approved the change in designation of Mr. Ravindra Kumar Kothari (DIN: 03418320) from Non-Executive Director to Whole-Time Director 3. Approved the change in designation of Mr. Virupakshaya Himesh (DIN: 08554422) from Whole-Time Director to Non-Executive Director with effect from October 1 20264. Approved the proposal to make investment in the proposed Joint Venture entity to be incorporated in the Republic of the Philippines5 approved the allotment of 10 00 000 (Ten Lakhs) Warrants to Mr. Shailesh Siroya Promoter of the Company on preferential basis
1 month agoBoard of directors of the Company met on Wednesday August 12 2026 inter alia transacted the following business.1. Considered and approved the unaudited Financial Results (Standalone and Consolidated) of the Company quarter ended on 30th June 20262. Approved the change in designation of Mr. Ravindra Kumar Kothari (DIN: 03418320) from Non-Executive Director to Whole-Time Director 3. Approved the change in designation of Mr. Virupakshaya Himesh (DIN: 08554422) from Whole-Time Director to Non-Executive Director with effect from October 1 20264. Approved the proposal to make investment in the proposed Joint Venture entity to be incorporated in the Republic of the Philippines5 approved the allotment of 10 00 000 (Ten Lakhs) Warrants to Mr. Shailesh Siroya Promoter of the Company on preferential basis
1 month agoScrutinizers Report Pertaining to Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23rd 2026.
1 month agoScrutinizers Report Pertaining to Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23rd 2026.
1 month agoOutcome : Result of Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23 2026
1 month agoOutcome : Result of Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23 2026
1 month agoBal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of Bal Pharma Limited is scheduled to be held on Wednesday August 12 2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2026 (Q1/2026-27) and such other matters as may be considered necessary with the permission of the Chair.
1 month agoBal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of Bal Pharma Limited is scheduled to be held on Wednesday August 12 2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2026 (Q1/2026-27) and such other matters as may be considered necessary with the permission of the Chair.
1 month agoCompany Providing opportunity to shareholders to Submit their Comments on Corrigendum to the Postal ballot notice
1 month agoCompany Providing opportunity to shareholders to Submit their Comments on Corrigendum to the Postal ballot notice
1 month agoIn Continuation of Postal Ballot Notice dated 09th July 2026 Submitting Corrigendum as integral part to the Said Notice.
1 month agoIn Continuation of Postal Ballot Notice dated 09th July 2026 Submitting Corrigendum as integral part to the Said Notice.
1 month agoCertificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended 30.06.2026
2 months agoCertificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended 30.06.2026
2 months agoPostal Ballot Notice for consider the issue of 1000000 Warrants to Mr. Shailesh Siroya promoter of the Company on preferential basis
2 months agoPostal Ballot Notice for consider the issue of 1000000 Warrants to Mr. Shailesh Siroya promoter of the Company on preferential basis
2 months agoThis is with reference to our earlier intimation dated 27th May 2026 regarding appointment of Mr. Shreepada ML as company secretary and compliance officer of the company pursuant to the approval of the board of directors at its meeting held on 27th may 2026 we hereby confirm that Mr. Shreepada ML (M No A66681) has taken charge and commenced his duties as the company Secretary and compliance officer (KMP) of the Company with effect from 23rd June 2026.
2 months agoThis is with reference to our earlier intimation dated 27th May 2026 regarding appointment of Mr. Shreepada ML as company secretary and compliance officer of the company pursuant to the approval of the board of directors at its meeting held on 27th may 2026 we hereby confirm that Mr. Shreepada ML (M No A66681) has taken charge and commenced his duties as the company Secretary and compliance officer (KMP) of the Company with effect from 23rd June 2026.
2 months agoTrading window closure for the quarter ended 30.06.2026.
2 months agoTrading window closure for the quarter ended 30.06.2026.
2 months agoWe are submitting the newspaper advertisements of the Audited financial results ( standalone & Consolidated ) for the quarter and financial year ended 31.03.2026 announced by the Company on 27.05.2026 and published in Financial express (English ) and Sanjayvani ( Kannada) on 29.05.2026.
3 months agoWe are submitting the newspaper advertisements of the Audited financial results ( standalone & Consolidated ) for the quarter and financial year ended 31.03.2026 announced by the Company on 27.05.2026 and published in Financial express (English ) and Sanjayvani ( Kannada) on 29.05.2026.
3 months agoFiling of Statement of deviation & variation is not applicable to the Company for the quarter ended 31.03.2026.
3 months agoFiling of Statement of deviation & variation is not applicable to the Company for the quarter ended 31.03.2026.
3 months agoAudited financial results of the company for the quarter and financial year ended 31.03.2026.
3 months agoAudited financial results of the company for the quarter and financial year ended 31.03.2026.
3 months agoBoard of Directors of the Company has met today and transacted following business 1. Approved audited financial results of the Company for the quarter and financial year ended 31.03.2026.2.Recommend dividend of Rs1.20 per equity share of Rs.10 each i.e 12%3.Appointed Cost Auditors and Internal auditors for the financial year 2026.27.4. Approved grant of 5 00 000 stock options to the employees of the company under "Bal Pharma Ltd-Employee Stock Option Plan-2025"5.Approved preferential issue of 10 00 000 warrants to the promoters.6. Take shareholders approval for preferential issue through postal ballot.7.Approved appointment of Mr.Shreepada M.L (M # A66681) as Company Secretary and compliance officer of the company.
3 months agoIn addition to the agenda items mentioned in our board meeting notice dated 18.05.2025 the following agenda item will also be considered at the meeting scheduled on 27.05.2026.1. To consider and approve proposal for fund raising through preferential issue of warrants to promoters.All other details and agenda items will remain unchanged.Please take this intimation on record.
4 months agoIn addition to the agenda items mentioned in our board meeting notice dated 18.05.2025 the following agenda item will also be considered at the meeting scheduled on 27.05.2026.1. To consider and approve proposal for fund raising through preferential issue of warrants to promoters.All other details and agenda items will remain unchanged.Please take this intimation on record.
4 months agoAnnual Secretarial Compliance Report for the financial year ended 31.03.2026.
4 months agoAnnual reports
Concalls & investor presentations
Aug 2022
ConcallPresentation